Repository: UIHistories Project: Board of Trustees Minutes - 1954 [PAGE 481]

EXTRACTED TEXT FROM PAGE:

478

BOARD OF TRUSTEES

[November 28

and Educational Hospitals, to serve also as Acting Dean of the College of Medicine from January I, 1953, until a new Dean is appointed, but not later than September 1, 1953, with the usual temporary salary addition for such service.

For action on this, see page 483. — Secretary's note.

PRESIDENT'S REPORTS ON KREBIOZEN AND THE MEDICAL SITUATION Report of November 14, 1952, on the Status of Krebiozen My report on Krebiozen embodying the recommendations of the Research Validation Committee (the Cole Committee), together with further proposals of the President of the University, was approved by the Board of Trustees on September

24, 1952.

It will be recalled that my recommendations were as follows: " ( 1 ) That in essence the recommendations of the Cole Committee be carried out. " ( 2 ) That Dr. Ivy be requested to secure from the owners or originators of Krebiozen all data, descriptions and formulations necessary to ascertain the chemical nature of Krebiozen and to undertake its biological preparation; that throughout such work there be no infringement of the technical, legal or financial rights of the originators. " ( 3 ) That, pending the completion of these chemical and biological studies, there be no further clinical uses or determinations of Krebiozen on the part of staff members of the University of Illinois except to continue the treatment of patients already using Krebiozen if the attending physicians so recommend. " ( 4 ) That in carrying out these plans the University make the necessary appropriations for work in its own laboratories and/or on a contractual basis with outside laboratories or firms. " ( 5 ) That the President of the University designate a Committee of Supervision consisting of three distinguished staff members of the University of Illinois whose academic and professional work especially fits them for such an assignment. (The three staff members listed by the President accepted a place on the Committee and have served accordingly. They are: Professor Robert E. Johnson, Chairman, Head of the Department of Physiology and Acting Dean of the Graduate College; Professor Harry F. Dowling, Head of the Department of Medicine and former head of the Department of Preventive Medicine; Professor Richard J. Winzler, Head of the Department of Biological Chemistry.) "If for any reason the originators of Krebiozen can not or will not cooperate effectively in carrying out this plan, I shall ask that there be no allowance of time, funds, space, equipment, patients or printing in behalf of any staff member of the University of Illinois for the clinical utilization of Krebiozen, and that every effort be made to dissociate Krebiozen from research or service programs. This action would be consistent with the major recommendations of the Cole Committee in which I have full confidence; it would, I believe, merit the support of all medical men familiar with these events." Following the approval of this report, the action in Paragraph No. (3) above became effective, and there has not been any "further clinical uses or determinations of Krebiozen on the part of staff members of the University of Illinois." Inclosed with my report is the official report of the Committee of Supervision dated November 12, 1952. (Attachment I is not inclosed inasmuch as it involves some material that was marked "personal.") The gist of the Johnson Report is that it has received from the originators of Krebiozen no materials with which to work and no useful description of the method of production of Krebiozen. The Committee, therefore, submits its final report and asks to be discharged. I am acting accordingly as of this date. The effect of this research impasse is twofold: A. That the action of Paragraph No. (3) of my report of September 24th now becomes permanent — there are to be no further clinical uses or determinations of Krebiozen on the part of staff members of the University of Illinois at any time.